Curaleaf Reports Strong Preliminary Q4 2025 Revenue Exceeding Guidance, Exits Hemp and Missouri Operations

summarizeSummary

Curaleaf Holdings announced preliminary unaudited Q4 2025 results, with net revenue of at least $330 million, surpassing previous guidance, alongside strategic decisions to discontinue its hemp business and exit Missouri.

check_boxKey Events

• Preliminary Q4 2025 Revenue Exceeds Guidance

  Net revenue for Q4 2025 is expected to be at least $330 million, representing approximately 4% sequential growth and 1% year-over-year growth, surpassing the company's previous guidance of low single-digit growth.

• Strong Adjusted Gross Profit Margin Maintained

  Fourth quarter adjusted gross profit margin is anticipated to be approximately 48.5%, with the full year 2025 adjusted gross margin expected to be around 50%.

• Strategic Business Exits Announced

  Curaleaf is discontinuing its hemp division due to new federal regulations and exiting its Missouri operations, which collectively contributed approximately $2 million in revenue in Q3 2025.

• Focus on Balance Sheet and Refinancing

  Management reiterated its commitment to maintaining a robust balance sheet and completing the refinancing of its senior secured notes due December 2026.

auto_awesomeAnalysis

The preliminary fourth-quarter results indicate solid operational performance, with revenue growth exceeding the company's prior guidance. The strategic decision to exit the low-revenue hemp and Missouri operations, driven by regulatory changes and sub-scale presence, suggests a focus on optimizing the business and improving future profitability. This "Return to Our Roots" strategy aims to build a stronger foundation for 2026, which could be viewed favorably by investors.